Submit Deal

TENTARIX BIOTHERAPEUTICS

Summary

Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 52 M

Avg. Deal Size£ 52 M

Market Context

Senior Management

Paul Grayson
CEO

Sort

15 Aug 2023|United States|Biotechnology

Target: TENTARIX BIOTHERAPEUTICS

Bidder: GILEAD SCIENCES

3 Service Providers

1 Target | 2 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 52 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy